https://www.dxrx.io/en_US/publications-and-reportsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articlesdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcastsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reportsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinarsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resourcesdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/coming-soondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/precision-medicine-webinarsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/dxrx-live-for-labsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/publications-and-reports/ivdr-report-updates-2025daily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/unlock-the-future-of-cancer-treatment-targeted-therapies-from-a-european-perspectivedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/oncogenic-fusion-detection-bridging-the-gap-from-clinic-to-labdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/the-pathology-oncology-connection-labs-in-action-why-this-dynamic-partnership-drives-precisiondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/the-hematopathology-team-from-slide-to-strategydaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/building-expertise-in-the-lab-dxrx-and-the-evolving-role-of-technicians-in-haemato-oncologydaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/leadership-in-blood-cancer-diagnostics-how-dxrx-empowers-lab-directors-to-innovate-and-leaddaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/elevating-pathology-in-blood-cancer-care-the-dxrx-advantage-in-collaborative-diagnosticsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/the-pathology-oncology-connection-labs-in-actiondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/testing-for-nrg1-fusions-the-seriesdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/testing-for-nrg1-fusions-series-so-fardaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/exploring-inherited-cancer-from-clinic-to-labdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/publications-and-reports/ivdr-report-update-2024daily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/ovarian-cancer-the-importance-of-testing-for-genomic-instability-in-addition-to-brca1-2daily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/overcome-the-challenges-of-implementing-new-biomarker-tests-in-labsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/artificial-intelligence-in-prostate-cancer-from-clinic-to-labdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/early-awareness-campaigns-obtain-better-resultsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/germline-and-somatic-brca-testing-in-metastatic-prostate-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/catch-up-on-the-series-fgfr3-testing-in-bladder-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/fgfr3-testing-in-bladder-cancer-recording-now-availabledaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/catch-up-on-the-series-nrg1-fusions-testingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/celebrating-30-years-of-alk-from-discovery-to-precision-medicine-breakthroughsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/dxrx-lab-talk-nrg1-fusions-testingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/esmo-2024-highlightsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/iss-named-as-italy-s-first-notified-body-under-the-eu-s-ivd-regulation-what-this-means-for-thedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/selecting-the-right-cdx-partner-insights-from-diaceuticsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/pathogenic-gene-fusions-are-key-actionable-biomarkers-in-precision-oncologydaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/oncogenic-fusion-detection-and-reporting-in-nsclc-and-solid-tumors-from-clinic-to-labdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/radioligand-therapy-how-is-this-transforming-radiotherapy-into-a-precision-medicine-treatmentdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/fgfr3-testing-in-bladder-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/maximizing-precision-medicine-adoption-commercial-and-clinical-benefits-of-targeted-physiciandaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/the-clinical-relevance-of-fgfr3-testing-in-bladder-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/closing-the-gaps-in-biomarker-testing-a-q-and-a-with-precision-medicine-expert-dr-ying-liu-ondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/publications-and-reports/ntrk-positivity-and-conversion-to-appropriate-personalized-treatmentdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/catch-up-on-the-series-her2-testing-in-breast-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/kit-d816v-testung-bei-systemischer-mastozytose-sm-kompakt-dargestelltdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/a-new-perspective-on-her2-testing-and-expressiondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/data-fact-sheet-nsclcdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/the-evolving-spectrum-of-her2-expressiondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/unleashing-the-potential-of-the-microbiome-in-precision-medicine-a-new-frontier-for-pharmadaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/embracing-precision-medicine-the-heart-of-value-based-caredaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/asco-2024-highlights-blogdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/kit-d816v-in-patienten-mit-systemischer-mastozytose-die-aufnahme-ist-jetzt-verfuegbardaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/navigating-the-new-amendments-to-the-eu-in-vitro-devices-regulation-ivdrdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/targeted-therapies-in-cancer-from-clinic-to-labsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/gain-valuable-insights-from-dxrx-data-to-commercialise-your-therapy-ddpsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-relevance-of-brca1-2-testing-in-advanced-prostate-cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resources/economic-summit-recording-forum-members-panel-discussion-the-recommendationsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/fda-s-final-rule-for-ldt-regulation-reshaping-the-diagnostic-landscapedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resources/the-evidence-suite-volume-2daily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resources/the-evidence-suite-volume-1daily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resources/impact-of-clinical-practice-gaps-on-the-implementation-of-personalized-medicine-in-advanced-nondaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/economic-summit-resources/the-axis-for-change-series-of-reportsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/targeted-therapies-in-gastric-cancer-from-clinic-to-labsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/precision-medicine-in-solid-tumorsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/precision-medicine-in-oncologydaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/bridging-the-practice-gaps-insights-from-susanne-munksted-ahead-of-the-precision-medicinedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/ovarian-cancer-meaningful-brca-testingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/navigating-the-evolving-landscape-of-companion-diagnostic-cdx-commercializationdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/braf-testing-in-metastatic-colorectal-cancer-series-at-a-glancedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/die-wichtige-bedeutung-der-kit-d816v-analyse-bei-patienten-mit-fortgeschrittener-systemischerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/coming-soon/multi-stakeholder-group-bring-a-unique-economic-solution-to-the-clinical-practice-gaps-holdingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/precision-medicine-beyond-oncology-precision-neurologydaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/precision-medicine-linking-rare-disease-patients-to-targeted-therapies-with-dxrx-signaldaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/rare-disease-day-2024-proud-to-be-bluedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/expert-opinion-ldt-regulation-by-fda-balancing-safety-innovation-and-patient-access-to-testingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/navigating-precision-medicine-challenges-in-imidsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/Colorectal cancer and BRAF V600E testing: Recording now availabledaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/levelling-up-series-part-1-time-to-level-up-testing-and-treatmentdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/seamless-diagnostic-testing-12-recommendations-from-our-precision-medicine-expert-to-drive-yourdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/publications-and-reports/global-ring-study-to-investigate-the-comparability-of-total-assay-performance-of-commercialdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/Colorectal cancer and BRAF V600E testingdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/reports/The clinical significance of BRAF V600E testing in metastatic colorectal cancerdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/from-drug-discovery-to-delivery-ai-s-impact-on-pharma-and-precision-medicinedaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/podcasts/the-better-testing-better-treatment-podcastsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/digital-pathology-and-artificial-intelligence-the-path-to-a-digitally-driven-workflowdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/coming-soon/the-transformative-role-of-liquid-biopsy-in-precision-medicine-diagnosticsdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/will-lab-benefit-managers-lbms-hinder-or-improve-access-to-precision-medicine-testing-in-the-usdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/liquid-biopsy-monthdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-rare-disease-series-autoantibodies-in-the-diagnosis-and-classification-of-sle-clinical-anddaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/articles/advancing-precision-medicine-in-cardiology-navigating-testing-challenges-for-enhanced-patientdaily0.72026-04-03T22:11:43.858Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-liquid-biopsy-series-breast-cancerdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/podcasts/the-better-testing-better-treatment-podcastdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/the-evolving-role-of-liquid-biopsy-from-advanced-disease-monitoring-to-an-emerging-tool-fordaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/expert-opinion-navigating-the-fda-pilot-program-in-oncology-drugs-with-in-vitro-diagnostic-testsdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/coming-soon/the-liquid-biopsy-series-mrddaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-liquid-biopsy-series-gynecological-and-urinary-cancerdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/economic-summit-resources/delivering-the-precision-oncology-paradigmdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-liquid-biopsy-series-liquid-biopsy-in-non-small-cell-lung-cancerdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/expert-opinion-will-fda-s-newly-launched-minimum-characteristics-pilot-program-drive-ldts-to-bedaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/measurable-residual-disease-syndicated-reportdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-liquid-biopsy-series-precision-medicine-the-impact-of-liquid-biopsydaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-rare-disease-series-wilson-s-diseasedaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/overcoming-clinical-diagnostic-testing-barriers-in-precision-medicinedaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/coming-soon/hrd-in-clinical-practice-where-are-we-nowdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/precision-medicine-webinars/practice-gaps-webinar-series-part-3daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/dxrx-live-for-labs/celebrating-ascp-annual-medical-laboratory-professionals-weekdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/folate-receptor-alpha-fra-in-ovarian-cancer-utilizing-this-biomarker-to-support-clinicaldaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/precision-medicine-readiness-report-2020-nsclc-an-axis-for-changedaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/precision-medicine-readiness-report-2019-part-1daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/esmo-targeted-anticancer-therapies-congress-features-new-poster-on-reproducibility-anddaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/the-latest-precision-medicine-readiness-report-is-available-nowdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/precision-medicine-readiness-report-part-3-unlocking-the-power-of-the-diagnostic-pathwaydaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/precision-medicine-webinars/practice-gaps-webinar-series-part-2daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/when-rare-becomes-the-norm-part-2daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/aiming-for-targets-in-pancreas-and-biliary-cancer-new-possibilities-to-hitdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/integrate-ceacam5-ihc-laboratory-testing-for-treatment-decisions-in-nsclc-patientsdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/fda-minimal-criteria-diaceutics-opiniondaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/san-antonio-breast-cancer-symposium-sabcs-2022-features-new-poster-on-her2-low-breast-cancerdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/integrating-folate-receptor-alpha-fra-ihc-testing-in-ovarian-cancer-todaydaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/companion-diagnostics-and-emerging-biomarkers-a-year-end-reviewdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/ntrk-testing-molecular-and-therapeutic-perspectivedaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/articles/when-rare-becomes-the-norm-part-1daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/dxrx-live-for-labs/new-precision-oncology-advances-in-diagnostic-testing-and-software-daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/biomarkers-in-colorectal-cancer-daily-strugglesdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/monitoring-residual-disease-in-aml-a-review-to-highlight-the-need-for-a-standardised-approachdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/lab-talks-and-webinars/the-evolution-of-her2-assessment-in-the-treatment-of-breast-cancerdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/non-small-cell-lung-cancer-nsclc-pd-l1-testing-landscape-challenges-in-the-context-of-upcomingdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/association-for-molecular-pathology-amp-2021-poster-st42daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/san-antonio-breast-cancer-symposium-sabcs-2021-posterdaily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/precision-medicine-webinars/practice-gaps-webinar-series-part-1daily0.72026-04-03T22:11:43.861Z https://www.dxrx.io/en_US/publications-and-reports/a-preliminary-review-of-adoption-of-new-hcpcs-codes-for-ngs-in-cms-claimsdaily0.72026-04-03T22:11:43.861Z